Brett P. Monia

Brett P. Monia, Ph.D. is a founding member and the current CEO of Ionis Pharmaceuticals, a pioneer in antisense drug development. Dr. Monia joined Isis Pharmaceuticals (now Ionis) at the time of its founding from SmithKline & French Laboratories, the predecessor of GlaxoSmithKline. His initial role as a senior scientist was followed by director-level positions of increasing responsibility in R&D. In 2018 Dr. Monia was promoted to chief operating officer and SVP of translational medicine and in 2020 to the role of chief executive officer. During his tenure at the company, Ionis has advanced its antisense platform from a nascent technology to one with a recognized potential that has been licensed to pharmaceutical and biotechnology partners worldwide.

Dr. Monia holds Bachelor of Science degrees in chemistry and biology from Stockton University and a Ph.D. in pharmacology from the University of Pennsylvania.